Vimentin as a poor prognostic factor for triple-negative breast cancer (Q39203704)

10 September 2017

title

Vimentin as a poor prognostic factor for triple-negative breast cancer (English)

1 reference

10 September 2017

1 reference

10

Yoshihiko Maehara

1 reference

10 September 2017

Nami Yamashita

1

1 reference

10 September 2017

Eriko Tokunaga

2

1 reference

10 September 2017

Hiroyuki Kitao

3

1 reference

10 September 2017

Yuichi Hisamatsu

4

1 reference

10 September 2017

Kenji Taketani

5

1 reference

10 September 2017

Sayuri Akiyoshi

6

1 reference

10 September 2017

Satoko Okada

7

1 reference

10 September 2017

Shinichi Aishima

8

1 reference

10 September 2017

Masaru Morita

9

1 reference

10 September 2017

publication date

26 January 2013

1 reference

Journal of Cancer Research and Clinical Oncology

10 September 2017

published in

1 reference

10 September 2017

volume

139

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

739-746

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-013-1376-6

10 September 2017

exact match

0 references

cites work

Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Triple-negative breast cancer: therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Pattern of metastatic spread in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Intermediate filament associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Cancer metastasis: building a framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Multiple roles for the receptor tyrosine kinase axl in tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Breast cancer adjuvant therapy: time to consider its time-dependent effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

WT-1 is required for early kidney development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Does vimentin help to delineate the so-called 'basal type breast cancer'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Dissecting the heterogeneity of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Vimentin in cancer and its potential as a molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Vimentin expression is not associated with poor prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1376-6

Vimentin expression does not assist in predicting survival in ductal carcinoma of the breast

21 January 2018

1 reference

12 December 2020

Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas

1 reference

12 December 2020

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

12 December 2020

Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.

1 reference

12 December 2020

10.1007/S00432-013-1376-6

Identifiers

DOI

1 reference

10 September 2017

1 reference